An angiogenic factor comprising a mixture of proteins derived from bone. The angiogenic protein mixture is produced by a series of steps that allow the proteins to be kept in solution. The angiogenic mixture of bone proteins is produced by a multi-step process that includes at least one ultrafiltration step, an anion exchange chromatography step, a cation exchange chromatography step and a high performance liquid chromatography (HPLC) purification step.

 
Web www.patentalert.com

< Electrokinetically pumped high pressure sprays

< Method and apparatus for the controlled formation of cavitation bubbles

> Combination for site-specifically transforming cells in vivo comprising a double-balloon catheter and nucleic acid comprising a gene encoding P21

> 19-norbufalin derivatives, their preparation and pharmaceutical compositions containing them

~ 00279